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On average, more than two new species of human virus are reported every year. We constructed the
cumulative species discovery curve for human viruses going back to 1901. We ﬁtted a statistical model to
these data; the shape of the curve strongly suggests that the process of virus discovery is far from complete.
We generated a 95% credible interval for the pool of as yet undiscovered virus species of 38–562. We
extrapolated the curveand generated an estimate of 10–40 new species to be discovered by 2020. Although
we cannot predict the level of health threat that these new viruses will present, we conclude that novel virus
species must be anticipated in public health planning. More systematic virus discovery programmes,
covering both humans and potential animal reservoirs of human viruses, should be considered.
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1. INTRODUCTION
Despite long-standing interest in global biodiversity (May
1988), only recently has the diversity of human pathogens
been catalogued (Taylor et al. 2001). Approximately 1400
pathogen species are currently recognized (Woolhouse &
Gaunt 2007). Fewer than 200 of these are viruses, but
novel virus species are being reported in humans at a rate
of over two per year, much faster than for other kinds of
pathogen (Woolhouse & Gaunt 2007). Novel viruses are a
major public health concern, whether causing disease on
the massive scale of HIV/AIDS, more transient events
such asthe SARS epidemic or potential future threats such
as pandemic inﬂuenza. An analysis of temporal patterns of
virus discovery is therefore of considerable interest.
Our analysis is based on the rate of accumulation of
new human virus species: the ‘discovery curve’. Discovery
curves have previously been used to estimate the total
diversity of various plant and animal taxa (Dove & Cribb
2006; Bebber et al. 2007). However, to our knowledge, the
discovery curves have not previously been compiled for
any category of human pathogen. Having compiled the
discovery curve, we proceed to develop a simple statistical
model which we use to estimate the size of the pool of
human virus species, N, and the expected rate of discovery
of new species to 2020.
2. MATERIAL AND METHODS
A standard method for estimating numbers of species is to
extrapolate the cumulative species discovery curve (Bebber
et al. 2007). We gathered data for this curve by systematically
searching the primary literature for ﬁrst reports of human
infection with each of the currently recognized virus species,
using species as deﬁned by the International Committee on
Taxonomyof Viruses (ICTV; http://www.ictvonline.org/). We
note that the set of viruses we are interested in—those that
can infect humans—is a small subset of the total (over 1500
species according to ICTV) and, as is discussed below, not a
closed set because many of these viruses can also infect other
hosts (Taylor et al. 2001). We regard this as analogous to
constructing species discovery curves for any subdivision of
geographical range or habitat. As we demonstrate below, this
approachyields anexcellent description ofthe discovery curve.
We used piecewise linear regression to test for changes in
the slope of the discovery curve. The results suggested
upswings in 1930 (95% CI, 1929–1933) and 1954 (1953–
1956). We therefore restricted detailed analysis to the period
1954–2006.
We modelled discovery since 1954 assuming a total
number of species available to be discovered (the species
pool) of N virus species, each discovered in any given year
with probability p. The model was ﬁtted to the data and
assessed using Markov chain Monte Carlo (MCMC)-based
Bayesian inference, generating distributions and credible
intervals for the parameters. The model deﬁnes the expected
number of discovered viruses in year t as
ltðN;pÞ ZNpð1KpÞ
tK1; ð2:1Þ
where year tZ1 corresponds to 1954.
The binomial distribution B(N, p) can be accurately
approximated by a Poisson distribution with parameter Np
for the range of values of N and p of interest. We considered
ﬁtting a distribution for values of p; however, provided
individual p-values are low there is minimal improvement in
model ﬁt. Thus, for a set of model parameters, the likelihood
of observing data, XZ{xi}, the number of viruses discovered
for years 1 to k, is given by
LðXjN;pÞ Z
Y k
iZ1
expðKliðN;pÞÞl
xi
i ðN;pÞ
xi!
: ð2:2Þ
Parameter distributions for N and p were calculated using
MCMC simulation using a standard Metropolis algorithm
with ﬂat prior information. It was necessary to compute a
correlation matrix to deﬁne a joint proposal since N and p are
closely correlated. We monitored convergence using two
chains. Once they had converged, we had a burn in period of
10
5 samples.
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calculating the mean, trend in the mean and variance for
the number of virus species discovered per year (based on
ﬁve million simulations using best-ﬁt parameter values).
The model was extrapolated to year 2020 by calculating the
expected number of viruses discovered using the best-ﬁt
model. The 95% posterior prediction intervals were calcu-
lated using two million model simulations taking into account
parameter uncertainty (as given by data from 1954 to 2006)
and natural model simulation stochasticity.
As a validation exercise, the model was also ﬁtted to
the curve for accumulated virus families from 1954 using the
same methods, except that the Poisson approximation no
longer holds, so a binomial distribution was used. A family
(based on current ICTV classiﬁcations) was added to the
total when the ﬁrst post-1954 species was allocated to that
family. We tested the assumption that species can be
randomly assigned to families (weighted by the size of the
families) by noting the number of years in which 0, 1, 2, etc.
virus families were discovered. This was done one million
times to obtain a distribution for comparison with the
observed values.
3. RESULTS
From a comprehensive search of the primary literature, we
found 188 virus species that have been reported to infect
humans, going back to yellow fever virus in 1901 (table 1).
Since then, the number of human virus species discovered
in any given year has ranged from zero to six. As is typical
(Bebber et al. 2007), the cumulative species discovery
curve increases slowly initially and then more rapidly
(ﬁgure 1). Piecewise linear regression suggests no further
upswings since 1954, roughly corresponding to the advent
of tissue culture techniques for virus detection (ﬁgure 1).
We conﬁrmed that our model reproduced the observed
slight downward trend in the rate of discovery since
1954 (ﬁgure 1) and the observed variance in the data
from 1954 to 2006 (ﬁgure 2). The distribution of the
number of virus species discovered per year shows slight
overdispersion (meanZ2.69; varianceZ3.07; variance-
to-mean ratio greater than 1) which falls within the
predicted range (meanZ2.70 with 95% credible interval
2.41–3.00; varianceZ3.03 with interval 1.99–4.49).
Together, these results support our choice of model,
even though we do not explicitly consider heterogeneity in
the probability of discovering a given species in any one
year (p) or temporal variation in sampling effort, detection
techniques and reporting.
Noting that p and N are highly correlated (ﬁgure 3),
our best estimate for p is 0.015 (95% credible interval,
0.004–0.026) with 117 (38–562) so far undiscovered
virus species. Extrapolating the discovery curve, allowing
for parameter uncertainty and stochastic discovery,
we obtain a best estimate of 22 new species (10–40) by
2020 (ﬁgure 1).
Data on the cumulative discovery of new virus families
are also reproducible (ﬁgure 4). The predicted distri-
bution of the number of virus families discovered per year
(assuming random allocation of species to families)
compares favourably with the observed distribution
(ﬁgure 5). This provides further support for the appro-
priateness of our model.
Table 1. List of viruses ordered by year of ﬁrst report
a of
human infection.
year species family
1901 Yellow fever virus ﬂavi
1903 Rabies virus rhabdo
1907 Dengue virus ﬂavi
1907 Human papillomavirus papilloma
1907 Molluscum contagiosum virus pox
1907 Variola virus pox
1909 Poliovirus picorna
1911 Measles virus paramyxo
1919 Human herpesvirus 3 herpes
1921 Human herpesvirus 1 herpes
1931 Rift Valley fever virus bunya
1933 Inﬂuenza A virus orthomyxo
1933 Lymphocytic choriomeningitis virus arena
1933 St Louis encephalitis virus ﬂavi
1934 Cercopithecine herpes virus 1 herpes
1934 Japanese encephalitis virus ﬂavi
1934 Louping ill virus ﬂavi
1934 Mumps virus paramyxo
1934 Orf virus pox
1937 Tick-borne encephalitis virus ﬂavi
1938 Cowpox virus pox
1938 Eastern equine encephalitis virus toga
1938 Rubella virus toga
1938 Venezuelan equine encephalitis virus toga
1938 Western equine encephalitis virus toga
1940 Inﬂuenza B virus orthomyxo
1940 West Nile virus ﬂavi
1941 Bwamba virus bunya
1943 Newcastle disease virus paramyxo
1944 Sandﬂy fever Naples virus bunya
1944 Sandﬂy fever Sicilian virus bunya
1946 Colorado tick fever virus reo
1947 Omsk haemorrhagic fever virus ﬂavi
1948 Encephalomyocarditis virus picorna
1948 Human enterovirus C picorna
1949 Human enterovirus A picorna
1949 Human enterovirus B picorna
1950 Inﬂuenza C virus orthomyxo
1950 Vesicular stomatitis virus rhabdo
1951 Bunyamwera virus bunya
1952 California encephalitis virus bunya
1952 Murray Valley encephalitis virus ﬂavi
1952 Ntaya virus ﬂavi
1953 Human rhinovirus A picorna
1954 Human adenovirus B adeno
1954 Human adenovirus C adeno
1954 Human adenovirus E adeno
1955 Human adenovirus D adeno
1956 Chikungunya virus toga
1956 Human herpesvirus 5 herpes
1956 Human parainﬂuenza virus 2 paramyxo
1956 Ilheus virus ﬂavi
1957 Human adenovirus A adeno
1957 Human respiratory syncytial virus paramyxo
1957 Kyasanur forest disease virus ﬂavi
1957 Mayaro virus toga
1957 Wesselsbron virus ﬂavi
1958 Human parainﬂuenza virus 1 paramyxo
1958 Human parainﬂuenza virus 3 paramyxo
1958 Human parechovirus picorna
1958 Junin virus arena
1959 Banzi virus ﬂavi
1959 Guaroa virus bunya
(Continued.)
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year species family
1959 Powassan virus ﬂavi
1960 Human parainﬂuenza virus 4 paramyxo
1960 Human rhinovirus B picorna
1961 Caraparu virus bunya
1961 Catu virus bunya
1961 O’nyong-nyong virus toga
1961 Oropouche virus bunya
1962 Rio Bravo virus ﬂavi
1962 Sindbis virus toga
1963 Equine rhinitis virus A picorna
1963 Great Island virus reo
1963 Pseudocowpox virus pox
1963 Yaba monkey tumour virus pox
1964 Human herpesvirus 4 herpes
1964 Machupo virus arena
1964 Zika virus ﬂavi
1965 Chagres virus bunya
1965 Foot and mouth disease virus picorna
1965 Tanapox virus pox
1965 Wyeomyia virus bunya
1966 Changuinola virus reo
1966 Human coronavirus 229E corona
1966 Quaranﬁl virus unassigned
1966 Saimiriine herpesvirus 1 herpes
1967 Chandipura virus rhabdo
1967 Crimean-Congo haemorrhagic fever
virus
bunya
1967 Human coronavirus OC43 corona
1967 Human enterovirus D picorna
1967 Piry virus rhabdo
1967 Tacaiuma virus bunya
1968 Human herpesvirus 2 herpes
1968 Marburg virus ﬁlo
1968 Tataguine virus bunya
1970 Everglades virus toga
1970 Hepatitis B virus hepadna
1970 Lassa virus arena
1970 Punta Toro virus bunya
1971 Aroa virus ﬂavi
1971 BK virus polyoma
1971 Duvenhage virus rhabdo
1971 JC virus polyoma
1971 Vaccinia virus pox
1972 Bovine papular stomatitis virus pox
1972 Mokola virus rhabdo
1972 Monkeypox virus pox
1972 Norwalk virus calici
1972 Ross River virus toga
1973 Bangui virus bunya
1973 Dugbe virus bunya
1973 Hepatitis A virus picorna
1973 Kotonkan virus rhabdo
1973 Rotavirus A reo
1973 Tamdy virus bunya
1974 Getah virus toga
1975 B19 virus parvo
1975 Bhanja virus bunya
1975 Human astrovirus astro
1975 Lebombo virus reo
1975 Shuni virus bunya
1975 Thogoto virus orthomyxo
1976 Orungo virus reo
1976 Wanowrie virus bunya
(Continued.)
Table 1. (Continued.)
year species family
1977 Hepatitis delta virus unassigned
1977 Sudan Ebola virus ﬁlo
1977 Zaire Ebola virus ﬁlo
1978 Hantaan virus bunya
1978 Issyk-Kul virus bunya
1980 Human T-lymphotropic virus 1 retro
1980 Puumala virus bunya
1982 Human T-lymphotropic virus 2 retro
1982 Seoul virus bunya
1983 Candiru virus bunya
1983 Hepatitis E virus unassigned
1983 Human adenovirus F adeno
1983 Human immunodeﬁciency virus 1 retro
1984 Human torovirus corona
1984 Rotavirus B reo
1985 Borna disease virus borna
1986 European bat lyssavirus 2 rhabdo
1986 Human herpesvirus 6 herpes
1986 Human immunodeﬁciency virus 2 retro
1986 Kasokero virus bunya
1986 Kokobera virus ﬂavi
1986 Rotavirus C reo
1987 Dhori virus orthomyxo
1987 Sealpox virus pox
1987 Suid herpesvirus 1 herpes
1988 Barmah Forest virus toga
1988 Picobirnavirus birna
1989 European bat lyssavirus 1 rhabdo
1989 Hepatitis C virus ﬂavi
1990 Banna virus reo
1990 Gan Gan virus bunya
1990 Reston Ebola virus ﬁlo
1990 Semliki Forest virus toga
1990 Trubanaman virus bunya
1991 Guanarito virus arena
1992 Dobrava-Belgrade virus bunya
1993 Sin Nombre virus bunya
1994 Hendra virus paramyxo
1994 Human herpesvirus 7 herpes
1994 Human herpesvirus 8 herpes
1994 Sabia virus arena
1995 Bayou virus bunya
1995 Black Creek Canal virus bunya
1995 Cote d’Ivoire Ebola virus ﬁlo
1995 Hepatitis G virus ﬂavi
1995 New York virus bunya
1996 Andes virus bunya
1996 Australian bat lyssavirus rhabdo
1996 Juquitiba virus bunya
1996 Usutu virus ﬂavi
1997 Laguna Negra virus bunya
1998 Menangle virus paramyxo
1999 Nipah virus paramyxo
1999 Torque teno virus circo
2000 Whitewater Arroyo virus arena
2001 Baboon cytomegalovirus herpes
2001 Human metapneumovirus paramyxo
2003 SARS coronavirus corona
2004 Human coronavirus NL63 corona
2005 Human bocavirus parvo
2005 Human coronavirus HKU1 corona
2005 Human T-lymphotropic virus 3 retro
2005 Human T-lymphotropic virus 4 retro
a Full details of sources available from authors on request.
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We conclude that it is extremely probable that new human
viruses will continue to be discovered in the immediate
future;wearenot yetclose to the end of the virus discovery
curve. As a direct result of this, it is not possible to
estimate the size of the species pool for human viruses with
precision. However, in contrast to the negative assessment
by Bebber et al. (2007) of the use of incomplete species
accumulation curves, we consider that the upper and
lower limits to our estimate of the size of the species pool
are of interest and also have practical implications.
Current trends are consistent with a pool of at least 38
undiscovered species that will be reported at an average
rate of at least approximately one per year to 2020. In this
context, it is worth noting that three new species were
reported in 2007: two polyoma viruses, Ki and Wu, and a
reovirus, Melaka (Allander et al. 2007; Chua et al. 2007;
Gaynor et al. 2007). Other viruses may have been reported
but not yet classiﬁed. In practice, future rates of discovery
will, of course, be affected by any major advances in virus
detection technology or by any major shifts (upwards or
downwards) in the effort expended on virus discovery
programmes. Tissue culture was regarded as the ‘gold
standard’ for virus detection up until a few years ago when
molecular methods came to the fore (Storch 2007),
although there has not been a detectable increase in
discovery rates as a result. Indeed, it is striking that there
have been no dramatic changes in the pattern of virus
discovery for over 50 years; extrapolations from our data
should therefore provide a useful benchmark for probable
future discovery rates.
The upper limit for N is ﬁnite but large; we cannot rule
out hundreds of novel human viruses to be reported in the
future. There are two (not mutually exclusive) possible
explanations for such a high level of diversity. First, it
could reﬂect the largely unknown extant diversity of
viruses in the non-human animal reservoirs that constitute
the major source of emerging human pathogens (Taylor
et al. 2001; Woolhouse & Gaunt 2007). The majority of
human viruses are known to be capable of infecting non-
human hosts (almost exclusively mammals and birds), and
the animal origin of many apparently novel human viruses
(e.g. HIV1 and HIV2, SARS CoV, Nipah virus) has been
frequently remarked upon (Morse 1995; Woolhouse &
Gowtage-Sequeria 2005; Wolfe et al. 2007); indeed,
recently discovered viruses are even more likely to be
associated with a non-human reservoir (Woolhouse &
Gaunt 2007). All these observations are consistent with
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Figure 1. The discovery curve for human virus species.
Cumulative number of species reported to infect humans
(black circles and line). Statistically signiﬁcant upward
breakpoints are shown (vertical lines). Best-ﬁt curve (solid
line) and lower and upper 95% posterior prediction intervals
(dashed lines) for extrapolation to 2020.
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Figure 2. Approximate probability density of variance in
simulated data from 1954 to 2006 for the best-ﬁt model.
Arrow shows observed value.
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Figure 3. Approximate probability density function of
parameter p and N generated by MCMC methods (see
main text for details).
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Figure 4. Accumulation of virus families associated with
species discovered after 1954 (black circles and line). Best-ﬁt
curve (solid line) and lower and upper 95% posterior
prediction intervals (dashed lines) extrapolated to 2020.
Fitted parameter values are NZ25 (95% credible intervals
24–37) and pZ0.056 (0.027–0.089).
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in the last few decades is ecological ‘spillover’ from animal
populations rather than newly evolved specialist human
viruses. We have very limited knowledge of the diversity of
viruses present in most mammal and bird species (with
most attention having been paid to viruses of domestic
animals; Cleaveland et al. 2001), so it is unclear for how
long this process might continue.
An alternative explanation for a large pool of human
viruses is that this reﬂects a high rate of evolution (within
a reservoir population) of truly novel species capable of
infecting humans. This hypothesis is difﬁcult to test
directly without much more comprehensive sequence
data from both human and non-human virus populations.
We note that the ﬁnite upper limit for the current estimate
of N does not necessarily imply that the process of virus
discovery is not open-ended (as a result of the evolution
of new species) since there could be a low background
rate of virus evolution, which will remain once extant
diversity has been fully revealed. The balance between
revealing extant diversity and the continual evolution of
new species could be explored using a more complex
model than equation (2.1); however, the available data
are insufﬁcient to yield useful estimates of the additional
parameters required.
Although we cannot know in advance how big a threat
they will pose, novel human viruses must be anticipated in
public health planning and surveillance programmes for
emerging infectious diseases (King et al. 2006; Jones et al.
2008). However, current approaches tovirus discovery are
largely passive, usually relying on investigation of reports
of human disease with unfamiliar clinical symptoms and
uncertain aetiology. Recently, there have been calls for
more active discovery programmes for viruses and other
pathogens involving ‘systematic sampling and phylogeo-
graphic analysis of related pathogens in diverse animal
species’ (Wolfe et al. 2007). We consider that such calls are
supported by the results reported here.
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